These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
6. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698 [TBL] [Abstract][Full Text] [Related]
7. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Lidegaard O Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141 [TBL] [Abstract][Full Text] [Related]
8. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
9. Relationship of migraine headache and stroke to oral contraceptive use. Benson MD; Rebar RW J Reprod Med; 1986 Dec; 31(12):1082-8. PubMed ID: 3540297 [TBL] [Abstract][Full Text] [Related]
10. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study. Hannaford PC; Kay CR Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398 [TBL] [Abstract][Full Text] [Related]
11. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
12. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives. Roy S Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522 [TBL] [Abstract][Full Text] [Related]
13. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858 [TBL] [Abstract][Full Text] [Related]
14. [Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990]. Lidegaard O Ugeskr Laeger; 1993 Nov; 155(44):3550-8. PubMed ID: 8236576 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol. Akerlund M Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641 [TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and venous thromboembolism. Paul C N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290 [TBL] [Abstract][Full Text] [Related]
17. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic risks of oral contraception]. Monier L Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576 [TBL] [Abstract][Full Text] [Related]
19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
20. Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives. Hölschermann H; Terhalle HM; Zakel U; Maus U; Parviz B; Tillmanns H; Haberbosch W Thromb Haemost; 1999 Dec; 82(6):1614-20. PubMed ID: 10613644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]